LaFavers Kaice
Division of Nephrology and Hypertension, Department of Medicine, Indiana University School of Medicine, Evansville, IN 47708, USA.
Int J Mol Sci. 2022 Feb 1;23(3):1702. doi: 10.3390/ijms23031702.
In addition to being a leading cause of morbidity and mortality worldwide, sepsis is also the most common cause of acute kidney injury (AKI). When sepsis leads to the development of AKI, mortality increases dramatically. Since the cardinal feature of sepsis is a dysregulated host response to infection, a disruption of kidney-immune crosstalk is likely to be contributing to worsening prognosis in sepsis with acute kidney injury. Since immune-mediated injury to the kidney could disrupt its protein manufacturing capacity, an investigation of molecules mediating this crosstalk not only helps us understand the sepsis immune response, but also suggests that their supplementation could have a therapeutic effect. Erythropoietin, vitamin D and uromodulin are known to mediate kidney-immune crosstalk and their disrupted production could impact morbidity and mortality in sepsis with acute kidney injury.
脓毒症不仅是全球发病和死亡的主要原因,也是急性肾损伤(AKI)最常见的病因。当脓毒症导致急性肾损伤时,死亡率会急剧上升。由于脓毒症的主要特征是宿主对感染的反应失调,肾脏与免疫系统之间的串扰被破坏可能导致脓毒症合并急性肾损伤的预后恶化。由于免疫介导的肾损伤可能会破坏其蛋白质制造能力,对介导这种串扰的分子进行研究不仅有助于我们了解脓毒症的免疫反应,还表明补充这些分子可能具有治疗作用。已知促红细胞生成素、维生素D和尿调节蛋白可介导肾脏与免疫系统之间的串扰,它们的产生受到破坏可能会影响脓毒症合并急性肾损伤的发病率和死亡率。